Clinical Trials Browser

Phase 1 × Not yet recruiting × Dermatologic × Clear all

Carcinoma, Transitional Cell, Melanoma

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Phase 1 Not yet recruiting

250 enrolled

DermatologicGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT07476326 2026-04-03

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Phase 1 Not yet recruiting

120 enrolled

Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT07501117 2026-03-30

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Phase 1 Not yet recruiting

15 enrolled

Dermatologic

Uveal Melanoma

NCT07475572 2026-03-16

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

Phase 1 Not yet recruiting

120 enrolled

Dermatologic

Melanoma

NCT07237594 2026-03-11

REPLAY

Phase 1 Not yet recruiting

4 enrolled

Dermatologic

Melanoma

NCT07444606 2026-03-03

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

Phase 1 Not yet recruiting

50 enrolled

Dermatologic

Melanoma

NCT07401277 2026-02-10

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

Phase 1 Not yet recruiting

32 enrolled

Dermatologic

Keratosis, Actinic

NCT07320222 2026-01-06

CARE-Melanoma

Phase 1 Not yet recruiting

30 enrolled

Dermatologic

Melanoma

NCT07252661 2025-11-28

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Phase 1 Not yet recruiting

40 enrolled

DermatologicEndocrineGastrointestinalGenitourinaryHead & Neck

Thyroid cancer, medullary, Carcinoma, Renal Cell, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis

NCT06897735 2025-11-18

EDDIS-a1

Phase 1 Not yet recruiting

24 enrolled

DermatologicHead & NeckThoracic

Lung Neoplasms, Melanoma, Mouth Neoplasms

NCT07192471 2025-09-25

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

72 enrolled

DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07177937 2025-09-22

A Study of DXC014 in Patients With Advanced Solid Tumors.

Phase 1 Not yet recruiting

150 enrolled

DermatologicGenitourinaryThoracic

Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07183852 2025-09-19

GoTIL-01

Phase 1 Not yet recruiting

18 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT07107178 2025-08-06

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

Phase 1 Not yet recruiting

58 enrolled

DermatologicOther solid neoplasm

Advanced Melanoma

NCT07100925 2025-08-03

A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Phase 1 Not yet recruiting

20 enrolled

DermatologicOther solid neoplasm

Cutaneous Squamous Cell Carcinoma (CSCC)

NCT06385522 2025-07-08

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Phase 1 Not yet recruiting

37 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT06424626 2024-05-22

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

Phase 1 Not yet recruiting

60 enrolled

Dermatologic

Melanoma

NCT05903937 2023-06-15

HAITILS-PHP

Phase 1 Not yet recruiting

6 enrolled

Dermatologic

Uveal Melanoma, Melanoma

Clinical Trials

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

REPLAY

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

CARE-Melanoma

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

EDDIS-a1

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

A Study of DXC014 in Patients With Advanced Solid Tumors.

GoTIL-01

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

HAITILS-PHP